Condition: Monkeypox (Mpox) · Sponsor: Institute of Tropical Medicine, Belgium
This study aims to better understand how mpox is spreading in the DRC, how it affects different groups of people, and how well vaccines protect against it. The study is designed as a cross-sectional survey, meaning researchers will collect and analyze data from patients diagnosed with mpox at a single point in time. It will also use a case-control approach, comparing people who test positive for the virus to those who test negative, to identify risk factors and evaluate the effectiveness of the vaccine.
This description comes directly from the study's public registry record.
Laurens Liesenborghs, MD, PhD · 00000000000 · lliesenborghs@itg.be
Sarah Houben, PhD · shouben@itg.be
Always discuss trial participation with your own doctor first.
| Masina Mpox Treatment Center | Kinshasa, Masina, Democratic Republic of the Congo | Not Yet Recruiting |
| Masina Mpox Treatment Center | Kinshasa, Democratic Republic of the Congo | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06840860